The study also is published in this month s issue of the cancer journal Carcinogenesis. Our study suggests quercetin may be a potential non-hormonal approach to accomplishing that goal.
Prostate cancer is the second leading cause of cancer death in men in the United States.
It annually claims about 31,500 men, accounting for about 11 percent of male cancer-related deaths. The findings may lead to another treatment option for the nearly 200,000 men diagnosed with prostate cancer annually in the United States. It also may mean that eventually some men may not have to undergo castration, the current, commonly used treatment for advanced prostate cancer. However, Dr. Xing cautions, more research is required to determine whether the preliminary laboratory findings about quercetin translate into actual benefit for men either at risk or diagnosed with prostate cancer. Quercetin is an abundant, naturally occurring flavonoid compound.